Literature DB >> 1515464

Convenient synthesis of bifunctional tetraaza macrocycles.

T J McMurry1, M Brechbiel, K Kumar, O A Gansow.   

Abstract

A convenient synthesis of 4-nitrobenzyl-substituted macrocyclic tetraamines and their conversion to bifunctional poly(amino carboxylate) chelating agents is described. Cyclization of (4-nitrobenzyl)-ethylenediamine with appropriate BOC-protected amino disuccinimido esters in dioxane at 90 degrees C resulted in the formation of 12- and 14-membered ring diamides in 40% and 44% yield, respectively. A 12-membered macrocyclic triamide was also prepared in 44% yield by cyclization of N-(2-aminoethyl)-4-nitrophenylalaninamide with disuccinimidyl N-(tert-butoxycarbonyl)iminodiacetate. Deprotection (HCl/dioxane) and reduction with borane gave the substituted macrocyclic amines which were then alkylated with either bromoacetic acid or tert-butyl bromoacetate. Preparation of the isothiocyanate derivatives and 14C labeled chelating agents are described. Attempts to prepare a 9-membered macrocyclic diamide using this cyclization technique resulted instead in a 20% yield of a 10:1 mixture of isomeric fused 5,6 ring acylamidines. Deprotection (HCl/dioxane) and reduction with borane gave a substituted piperazine derivative in 55% yield.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515464     DOI: 10.1021/bc00014a004

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  14 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 2.  Bifunctional chelates for metal nuclides.

Authors:  M W Brechbiel
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-11-28       Impact factor: 2.346

Review 3.  Targeted alpha-therapy: past, present, future?

Authors:  Martin W Brechbiel
Journal:  Dalton Trans       Date:  2007-09-11       Impact factor: 4.390

4.  Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with (177)Lu: in vitro comparison of acyclic and macrocyclic ligands.

Authors:  Marc Hens; Ganesan Vaidyanathan; Phil Welsh; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2009-02       Impact factor: 2.408

5.  Strategies for labeling proteins with PARACEST agents.

Authors:  Olga Vasalatiy; Piyu Zhao; Mark Woods; Andrei Marconescu; Aminta Castillo-Muzquiz; Philip Thorpe; Garry E Kiefer; A Dean Sherry
Journal:  Bioorg Med Chem       Date:  2010-06-18       Impact factor: 3.641

6.  Application of 212Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical Translation.

Authors:  Kwon Yong; Martin Brechbiel
Journal:  AIMS Med Sci       Date:  2015-08-18

7.  Towards translation of 212Pb as a clinical therapeutic; getting the lead in!

Authors:  Kwon Yong; Martin W Brechbiel
Journal:  Dalton Trans       Date:  2011-03-04       Impact factor: 4.390

8.  Radiolabeling of a cyclic RGD (cyclo Arg-Gly-Asp-d-Tyr-Lys) peptide using sodium hypochlorite as an oxidizing agent.

Authors:  Stephanie Doll; Karen Woolum; Krishan Kumar
Journal:  J Labelled Comp Radiopharm       Date:  2016-08-31       Impact factor: 1.921

9.  Methodology for labeling proteins and peptides with lead-212 (212Pb).

Authors:  Kwamena E Baidoo; Diane E Milenic; Martin W Brechbiel
Journal:  Nucl Med Biol       Date:  2013-04-17       Impact factor: 2.408

10.  (S)-5-(p-nitrobenzyl)-PCTA, a promising bifunctional ligand with advantageous metal ion complexation kinetics.

Authors:  Gyula Tircsó; Eniko Tircsóné Benyó; Eul Hyun Suh; Paul Jurek; Garry E Kiefer; A Dean Sherry; Zoltán Kovács
Journal:  Bioconjug Chem       Date:  2009-03-18       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.